If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 67   2006   NUMBER 11

Original Articles

1665 Acupuncture for Depression: A Randomized Controlled Trial. John J. B. Allen, Rosa N. Schnyer, Andrea S. Chambers, Sabrina K. Hitt, Francisco A. Moreno, and Rachel Manber
[Abstract] [PDF]

1674 A Randomized, Double-Blind, Active-Control Study of Sertraline Versus Venlafaxine XR in Major Depressive Disorder. Richard C. Shelton, Kirsten L. Haman, Mark H. Rapaport, Ari Kiev, Ward T. Smith, Robert M. A. Hirschfeld, R. Bruce Lydiard, John M. Zajecka, and David L. Dunner
[Abstract] [PDF]

1682 The Boundary Between Hypochondriasis and Obsessive-Compulsive Disorder: A Cross-Sectional Study From the Netherlands. Anja Greeven, Anton J. L. M. van Balkom, Yanda R. van Rood, Patricia van Oppen, and Philip Spinhoven
[Abstract] [PDF]

1690 Prediction of Remission as a Combination of Symptomatic and Functional Remission and Adequate Subjective Well-Being in 2960 Patients With Schizophrenia. Martin Lambert, Benno G. Schimmelmann, Dieter Naber, Alexander Schacht, Anne Karow, Thomas Wagner, and Joerg Czekalla
[Abstract] [PDF]

1698 Adjunctive Topiramate Therapy in Patients Receiving a Mood Stabilizer for Bipolar I Disorder: A Randomized, Placebo-Controlled Trial. K. N. Roy Chengappa, Lesley K. Schwarzman, Joseph F. Hulihan, Jim Xiang, and Norman R. Rosenthal, for the Clinical Affairs Product Support Study-168 Investigators
[Abstract] [PDF]

1707 Remission in First-Episode Psychosis: Predictor Variables and Symptom Improvement Patterns. Robin Emsley, Piet P. Oosthuizen, Martin Kidd, Liezl Koen, Dana J. H. Niehaus, and H. Jadri Turner
[Abstract] [PDF]

1713 The Brown Longitudinal Obsessive Compulsive Study: Treatments Received and Patient Impressions of Improvement. [CME] Maria C. Mancebo, Jane L. Eisen, Anthony Pinto, Benjamin D. Greenberg, Ingrid R. Dyck, and Steven A. Rasmussen
[Abstract] [PDF]

1721 Incidence and Time Course of Subsyndromal Symptoms in Patients With Bipolar I Disorder: An Evaluation of 2 Placebo-Controlled Maintenance Trials. Mark A. Frye, Lakshmi N. Yatham, Joseph R. Calabrese, Charles L. Bowden, Terence A. Ketter, Trisha Suppes, Bryan E. Adams, and Thomas R. Thompson
[Abstract] [PDF]

1729 Efficacy and Tolerability of Open-Label Topiramate in the Treatment of Sleep-Related Eating Disorder: A Retrospective Case Series. John W. Winkelman
[Abstract] [PDF]

1735 Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder. Francisco A. Moreno, Christopher B. Wiegand, E. Keolani Taitano, and Pedro L. Delgado
[Abstract] [PDF]

1741 Which Factors Predict Placebo Response in Anxiety Disorders and Major Depression? An Analysis of Placebo-Controlled Studies of Escitalopram. Dan J. Stein, David S. Baldwin, Ornah T. Dolberg, Nicolas Despiegel, and Borwin Bandelow
[Abstract] [PDF]

1747 Olanzapine Versus Risperidone in the Treatment of Manic or Mixed States in Bipolar I Disorder: A Randomized, Double-Blind Trial. Roy H. Perlis, Robert W. Baker, Carlos A. Zarate, Jr., Eileen B. Brown, Leslie M. Schuh, Hassan H. Jamal, and Mauricio Tohen
[Abstract] [PDF]

1754 A Cross-Sectional Study of the Prevalence of Cognitive and Physical Symptoms During Long-Term Antidepressant Treatment. Maurizio Fava, Lesley M. Graves, Franco Benazzi, Margaret J. Scalia, Dan V. Iosifescu, Jonathan E. Alpert, and George I. Papakostas
[Abstract] [PDF]

1760 Association Between Enhanced Soluble CD40 Ligand and Proinflammatory and Prothrombotic States in Major Depressive Disorder: Pilot Observations on the Effects of Selective Serotonin Reuptake Inhibitor Therapy. Roberto Leo, Giorgio Di Lorenzo, Manfredi Tesauro, Cinzia Razzini, Giovanni B. Forleo, Gaetano Chiricolo, Clarissa Cola, Marco Zanasi, Alfonso Troisi, Alberto Siracusano, Renato Lauro, and Francesco Romeo
[Abstract] [PDF]

1767 Escitalopram Maintenance Treatment for Prevention of Recurrent Depression: A Randomized, Placebo-Controlled Trial. Susan G. Kornstein, Anjana Bose, Dayong Li, Khalil G. Saikali, and Chetan Gandhi
[Abstract] [PDF]

1776 Antidepressants and Driving Ability: Results From a Clinical Study. Alexander Brunnauer, Gerd Laux, Elisabeth Geiger, Michael Soyka, and Hans-Jürgen Möller
[Abstract] [PDF]

Focus on Alzheimer's Disease and Related Disorders

1782 A 100-Year Update on Alzheimer's Disease and Related Disorders. Eric M. Reiman
[PDF]

1784 Alzheimer's Disease A Century Later. Richard J. Caselli, Thomas G. Beach, Roy Yaari, and Eric M. Reiman
[Abstract] [PDF]

Academic Highlights

1801 New Developments in Addiction Treatment. [CME]
[PDF]

ASCP Corner

1813 Measurement-Based Psychiatry: Definitions of Response, Remission, Stability, and Relapse in Schizophrenia. Stefan Leucht and John M. Kane
[PDF]

A Psychiatrist's Diary

1815 Until Death Do Us Part. Shyam K. Bhat
[PDF]

Letters To the Editor

1817 Manic Switch in a Patient With Treatment-Resistant Bipolar Depression Treated With Modafinil. Jürgen Wolf, Ute Fiedler, Ion Anghelescu, and Natascha Schwertfeger
[PDF]

1817 Diagnostic and Therapeutic Challenges in Narcolepsy-Related Psychosis. Daniel Kondziella and Peter Arlien-Soborg
[PDF]

1819 Beneficial Effects of Prazosin for Visual Hallucinations Associated With Chronic Cocaine Abuse. Andre M. Tapp, Annette Kennedy, Elaine R. Peskind, and Murray A. Raskind
[PDF]

1820 Fluoxetine-Mirtazapine Interaction May Induce Restless Legs Syndrome: Report of 3 Cases From a Clinical Trial. Keiko A. Prospero-Garcia, Antonio Torres-Ruiz, Jesus Ramirez-Bermudez, Javier Velazquez-Moctezuma, Yoaly Arana-Lechuga, and Guadalupe Teran-Perez
[PDF]

1820 Tactile Hallucinations Associated With Therapeutic Doses of Bupropion in 2 Patients. Anthony Charuvastra and Deborah Yaeger
[PDF]

1821 Immediate Switching From Moclobemide to Duloxetine May Induce Serotonin Syndrome. Alejandro Jimenez-Genchi
[PDF]

Book Reviews 1823

Electronic CME Activities

e15 The Art and Science of Switching of Antipsychotic Medications, Part 1. Peter J. Weiden, Allan H. Young, and Peter F. Buckley

e16 Medical Risk in Patients With Bipolar Disorder and Schizophrenia. John W. Newcomer